Early and Sustained Survival Benefit Associated With Statin Therapy at the Time of Percutaneous Coronary Intervention

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Circulation

• Publication date

  2002-02-12

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/HC0602.103586PMID 11839623
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cholesterol Sulfate: A New Adhesive Molecule for Platelets

  2001cited by this paper
• Early statin treatment following acute myocardial infarction and 1-year survival.

  2001cited by this paper
• Effect of Hydroxymethyl Glutaryl Coenzyme A Reductase Inhibitor Therapy on High Sensitive C-Reactive Protein Levels

  2001cited by this paper
• Incremental Prognostic Value of Elevated Baseline C-Reactive Protein Among Established Markers of Risk in Percutaneous Coronary Intervention

  2001cited by this paper
• Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study.

  2001cited by this paper
• Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study.

  2001cited by this paper
• Increased Mortality With Oral Platelet Glycoprotein IIb/IIIa Antagonists: A Meta-Analysis of Phase III Multicenter Randomized Trials

  2001cited by this paper
• Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial.

  2001cited by this paper
• Cytomegalovirus Seropositivity and C-Reactive Protein Have Independent and Combined Predictive Value for Mortality in Patients With Angiographically Demonstrated Coronary Artery Disease

  2000cited by this paper
• Statin therapy, lipid levels, C-reactive protein and the survival of patients with angiographically severe coronary artery disease.

  2000cited by this paper
• Plasma levels of C-reactive protein after coronary stent implantation.

  2000cited by this paper
• Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease.

  2000cited by this paper
• Predictive value of C-reactive protein in patients with unstable angina pectoris undergoing coronary artery stent implantation.

  2000cited by this paper
• Long-Term Effects of Pravastatin on Plasma Concentration of C-reactive Protein

  1999cited by this paper
• Statins and C-reactive protein.

  1999cited by this paper
• A randomized placebo-controlled trial of fluvastatin for prevention of restenosis after successful coronary balloon angioplasty; final results of the fluvastatin angiographic restenosis (FLARE) trial.

  1999cited by this paper
• Effect of statins on C-reactive protein in patients with coronary artery disease.

  1999cited by this paper
• Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators.

  1999cited by this paper
• Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes. The RECIFE (reduction of cholesterol in ischemia and function of the endothelium) trial.

  1999cited by this paper
• Statins and C-reactive protein.

  1999cited by this paper
• Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group.

  1998cited by this paper
• Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors.

  1998cited by this paper
• HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages.

  1998cited by this paper
• Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: a potential mechanism of lesion stabilization.

  1998cited by this paper
• Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels.

  1998cited by this paper
• Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators.

  1998cited by this paper
• Predictive value of C-reactive protein after successful coronary-artery stenting in patients with stable angina.

  1998cited by this paper
• Effect of pravastatin on angiographic restenosis after coronary balloon angioplasty. The PREDICT Trial Investigators. Prevention of Restenosis by Elisor after Transluminal Coronary Angioplasty.

  1997cited by this paper
• Estimating Causal Effects from Large Data Sets Using Propensity Scores

  1997cited by this paper
• The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.

  1996cited by this paper
• Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication.

  1995cited by this paper
• Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease.

  1995cited by this paper
• The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion.

  1995cited by this paper
• Hyperlipidemia and coronary disease. Correction of the increased thrombogenic potential with cholesterol reduction.

  1995cited by this paper
• Inhibition of thromboxane biosynthesis and platelet function by simvastatin in type IIa hypercholesterolemia.

  1995cited by this paper
• Lack of effect of lovastatin on restenosis after coronary angioplasty. Lovastatin Restenosis Trial Study Group.

  1994cited by this paper
• Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

  1994cited by this paper
• Pravastatin inhibits cellular cholesterol synthesis and increases low density lipoprotein receptor activity in macrophages: in vitro and in vivo studies.

  1994cited by this paper

• Serial Assessment of Vascular Healing Process after Directional Coronary Atherectomy followed by Drug-Coated Balloon: An Optical Coherence Tomography Study.

  2026cites this paper
• Addressing adherence challenges in long-term statin treatment among Asian populations: Current gaps and proposed solutions

  2025cites this paper
• Efferocytosis in atherosclerosis

  2024cites this paper
• Long‐term outcomes after stent implantation in very small vessel coronary artery disease

  2023cites this paper
• Trends In ST-elevation Myocardial Infarction Hospitalisation Among Young Adults: A Binational Analysis.

  2023cites this paper
• Prognostic impact of treatments evolution in STEMI.

  2023cites this paper
• Concurrent Use of Statins in Patients Undergoing Curative Intent Treatment for Triple Negative Breast Cancer: A Systematic Review and Meta-Analysis.

  2023cites this paper
• PERIPROCEDURAL MYOCARDIAL INFARCTION: A REVIEW ARTICLE

  2022cites this paper
• Association of statin pretreatment with presentation characteristics, infarct size and outcome in older patients with acute coronary syndrome: the Elderly ACS-2 trial.

  2022cites this paper
• Prevention of Contrast-Induced Nephropathy After Cardiovascular Catheterization and Intervention With High-Dose Strong Statin Therapy in Japan　- The PREVENT CINC-J Study.

  2022cites this paper
• Lipid‐Lowering Trials Are Not Representative of Patients Managed in Clinical Practice: A Systematic Review and Meta‐Analysis of Exclusion Criteria

  2022cites this paper
• The relationship between long-term statin usage and myocardial injury related to percutaneous coronary interventions evaluated by high-sensitivity troponins.

  2021cites this paper
• Enzyme modified CNTs for biosensing application: Opportunities and challenges

  2021cites this paper
• Concurrent use of statins and neoadjuvant chemoradiotherapy for rectal cancer: a systematic review and meta-analysis

  2021cites this paper
• Addressing disparities of care in non-ST-segment elevation myocardial infarction patients without standard modifiable risk factors: insights from a nationwide cohort study.

  2021cites this paper
• A retrospective study on the preventive effect of statin after carotid artery stenting

  2021cites this paper
• Beneficial effect of statin on preventing contrast-induced acute kidney injury in patients with renal insufficiency

  2020cites this paper
• Targeting cardiovascular inflammation: next steps in clinical translation.

  2020cites this paper
• Impact of statin pretreatment on the complications of carotid stenting in asymptomatic patients: observational study

  2020cites this paper
• Preoperative Use of Statins in Carotid Artery Stenting: A Systematic Review and Meta-analysis

  2018cites this paper
• Protection from Reperfusion Injury with Intracoronary N-Acetylcysteine in Patients with STEMI Undergoing Primary Percutaneous Coronary Intervention in a Cardiac Tertiary Center

  2018cites this paper
• Impact of Omega-3 Supplementation on High Sensitive C-Reactive Protein Level and 30-Day Major Adverse Cardiac Events After the Implementation of Coronary Stent in Patients with Chronic Kidney Disease: A Randomized Clinical Study

  2018cites this paper
• Reduction of No Reflow with a Loading Dose of Atorvastatin before Primary Angioplasty in Patients with Acute ST Myocardial Infarction.

  2018cites this paper
• Outcome of Carotid Artery Endarterectomy in Statin Users versus Statin-Naïve Patients: A Systematic Review and Meta-Analysis.

  2018cites this paper
• Statin Therapy and Diabetes Do Not Affect Aneurysm Occlusion or Clinical Outcomes After Pipeline Embolization Device Treatment: A Preliminary Study.

  2018cites this paper
• Association Between Statin Use and Cardiovascular Events After Carotid Artery Revascularization

  2018cites this paper
• Pre-Procedural Statin Use Is Associated with Improved Long-Term Survival and Reduced Major Cardiovascular Events in Patients Undergoing Carotid Artery Stenting: A Retrospective Study

  2018cites this paper
• Hong et al Dose of Statin Pretreatment in Carotid Stenting 1891 Subjects and Methods Selection of Study Patients and Data Collection

  2017cites this paper
• Is HMG-Co A Reductase Inhibitor Use Associated with Improved Outcomes in Patients Undergoing Colorectal Cancer Resection?

  2017cites this paper
• Dose-Dependent Effect of Statin Pretreatment on Preventing the Periprocedural Complications of Carotid Artery Stenting

  2017cites this paper
• Observational Prospective study to esTIMAte the rates of outcomes in patients undergoing PCI with drug-eluting stent implantation who take statins –follow-up (OPTIMA II)

  2017cites this paper
• Efecto protector de diferentes dosis de atorvastatina en la evolución funcional y clínica de los pacientes sometidos a revascularización miocárdica

  2017cites this paper
• The efficacy of statin administration prior to elective percutaneous coronary intervention in reducing the incidence of post-procedural myocardial infarction or all-cause mortality : a systematic review

  2017cites this paper
• Periprocedural effects of statins on the incidence of contrast-induced acute kidney injury: A systematic review and trial sequential analysis.

  2016cites this paper
• Rosuvastatin for Reduction of Myocardial Damage during Coronary Angioplasty - the Remedy Trial

  2016cites this paper
• New Definition of Aging? Measuring Regenerative Capacity in Patients.

  2016cites this paper
• The combined effect of rosuvastatin and ischemic pre- or post-conditioning on myocardial ischemia-reperfusion injury in rat heart.

  2015cites this paper
• Efficacy of chronic statin therapy on major cardiac events after coronary artery bypass grafting: low-dose versus high-dose

  2015cites this paper
• Combination therapy reduces the incidence of no-reflow after primary per-cutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction

  2015cites this paper
• Expression of OATP2B1 as determinant of drug effects in the microcompartment of the coronary artery.

  2015cites this paper
• Efficacy of chronic statin therapy on major cardiac events after coronary artery bypass grafting: low-dose versus high-dose.

  2015cites this paper
• [Type 4a myocardial infarction].

  2014cites this paper
• Early high-dose rosuvastatin and cardioprotection in the protective effect of rosuvastatin and antiplatelet therapy on contrast-induced acute kidney injury and myocardial damage in patients with acute coronary syndrome (PRATO-ACS) study.

  2014cites this paper
• Effects of Statin Treatment on Early Outcomes and Restenosis after Carotid Stenting

  2014cites this paper
• Early high-dose rosuvastatin for contrast-induced nephropathy prevention in acute coronary syndrome: Results from the PRATO-ACS Study (Protective Effect of Rosuvastatin and Antiplatelet Therapy On contrast-induced acute kidney injury and myocardial damage in patients with Acute Coronary Syndrome).

  2014cites this paper
• Plasma Cholesterol–Induced Lesion Networks Activated before Regression of Early, Mature, and Advanced Atherosclerosis

  2014cites this paper
• Failure to initiate statin therapy during and after percutaneous coronary interventions negatively affects coronary artery bypass graft outcomes.

  2014cites this paper
• Meta-analysis of randomized controlled trials of preprocedural statin administration for reducing contrast-induced acute kidney injury in patients undergoing coronary catheterization.

  2014cites this paper
• Statin treatment before percutaneous cononary intervention.

  2013cites this paper
• Prehospital statin therapy and one-year mortality in patients with stable coronary artery disease undergoing percutaneous coronary intervention.

  2013cites this paper
• Comparison of high reloading ROsuvastatin and Atorvastatin pretreatment in patients undergoing elective PCI to reduce the incidence of MyocArdial periprocedural necrosis. The ROMA II trial.

  2013cites this paper
• Effect of a Single High Loading Dose of Rosuvastatin on Percutaneous Coronary Intervention for Acute Coronary Syndromes

  2013cites this paper
• Defining the Role of High-Dose Statins in PCI

  2013cites this paper
• Statins and percutaneous coronary intervention: a complementary synergy.

  2013cites this paper
• Statin Therapy in Heart Failure: For Good, for Bad, or Indifferent?

  2013cites this paper
• Statins in acute coronary syndrome: very early initiation and benefits

  2012cites this paper
• Assessment of Endothelial Function in Humans and the Endothelial-protective Effects of 3-hydroxy-3-methylglutaryl coenzyme A Reductase Inhibitors

  2012cites this paper
• Statins and stent thrombosis.

  2012cites this paper
• Periprocedural Myocardial Infarction in a Randomized Trial of Everolimus-Eluting and Paclitaxel-Eluting Coronary Stents: Frequency and Impact on Mortality According to Historic Versus Universal Definitions

  2012cites this paper
• "Endothelial progenitor cells" as a therapeutic strategy in cardiovascular disease.

  2012cites this paper
• Effect of statins therapy prior to percutaneous coronary intervention.

  2012cites this paper
• Statin loading before percutaneous coronary intervention to reduce periprocedural myocardial infarction.

  2012cites this paper
• Scientific Rationale for Combination of a Calcium Channel Antagonist and an HMG-CoA Reductase Inhibitor

  2012cites this paper
• Statin Intake Is Associated With Decreased Insulin Sensitivity During Cardiac Surgery

  2012cites this paper
• Comparison of the efficacy and safety of statin and statin/ezetimibe therapy after coronary stent implantation in patients with stable angina.

  2012cites this paper
• High Sensitivity C-Reactive Protein and Outcomes Following Percutaneous Coronary Intervention in Contemporary Practice

  2012cites this paper
• Mechanisms of Vascular Disease

  2012cites this paper
• Statins Reduce Incidence of Early Perioperative Complications and Length of in-Hospital Stay after Coronary Artery Bypass Graft Surgery

  2011cites this paper
• INCIDENCE AND PREDICTORS OF CARDIAC MARKERS ELEVATION AFTER CORONARY INTERVENTION

  2011cites this paper
• Effectiveness of Preprocedural Statin Therapy on Clinical Outcomes for Patients With Stable Coronary Artery Disease After Percutaneous Coronary Interventions

  2011cites this paper
• Treatment of severe idiopathic orbital inflammation with intravenous methylprednisolone

  2011influential citation
• An integer based risk score for predicting 30-day major adverse cardiac or cerebrovascular events after percutaneous coronary intervention with drug-eluting stents: results from a large prospective multicentre registry, the STENT Group.

  2011cites this paper
• Targeting the reperfusion injury salvage kinase pathway in the clinical setting

  2011cites this paper
• Clinical Benefit of Statin Pretreatment in Patients Undergoing Percutaneous Coronary Intervention: A Collaborative Patient-Level Meta-Analysis of 13 Randomized Studies

  2011cites this paper
• Mechanisms of Vascular Disease: A Reference Book for Vascular Specialists

  2011cites this paper
• Glycoprotein IIb/IIIa inhibitors: do they still have a role?

  2011cites this paper
• Clustering of metabolic abnormalities among obese patients and mortality after percutaneous coronary intervention.

  2011cites this paper
• Statins in non‐ischaemic cardiomyopathy: an update on our current clinical and pathophysiological understanding

  2011cites this paper
• Effect of coronary endothelial function on outcomes in patients undergoing percutaneous coronary intervention.

  2011cites this paper
• High-dose statin before percutaneous coronary intervention lowers risk of periprocedural myocardial infarction and 30-day major cardiac adverse events

  2011cites this paper
• LDL-LOWERING INDEPENDENT EFFECTS OF EARLY PRE-TREATMENT WITH HIGH-DOSE STATINS IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTIONS

  2011cites this paper
• Contrast-induced nephropathy: do statins offer protection?

  2011cites this paper
• Stents and statins: history, clinical outcomes and mechanisms

  2010cites this paper
• Chronic treatment with statins increases the availability of selenium in the antioxidant defence systems of hemodialysis patients.

  2010cites this paper
• Advances in Interventional Cardiology Periprocedural Myocardial Infarction Prevalence, Prognosis, and Prevention

  2010cites this paper
• Periprocedural Myocardial Infarction: Prevalence, Prognosis, and Prevention

  2010cites this paper
• Caracterização e impacto clínico tardio do no-reflow associado a intervenção coronária percutânea primária vs. eletiva

  2010cites this paper
• With Atorvastatin After Coronary Artery Bypass Grafting : A Prospective Randomized Study Clopidogrel Provides Significantly Greater Inhibition of Platelet Activity Than Aspirin When Combined

  2010cites this paper
• Clopidogrel Provides Significantly Greater Inhibition of Platelet Activity Than Aspirin When Combined With Atorvastatin After Coronary Artery Bypass Grafting: A Prospective Randomized Study

  2010cites this paper
• Effects of statins on early and late results of carotid stenting.

  2010cites this paper
• Usefulness of atorvastatin (80 mg) in prevention of contrast-induced nephropathy in patients with chronic renal disease.

  2010cites this paper
• Statin loading before percutaneous coronary intervention: proposed mechanisms and applications.

  2010cites this paper
• Statins and Their Role in Pre-Percutaneous Coronary Intervention

  2010cites this paper
• The endothelial-protective effects of HMG-CoA reductase inhibition in the setting of ischemia and reperfusion injury

  2010cites this paper
• Therapeutic advances in myocardial microvascular resistance: unravelling the enigma.

  2010cites this paper
• Effect of preoperative statin therapy on myocardial protection and morbidity endpoints following off-pump coronary bypass surgery in patients with elevated C-reactive protein level

  2010cites this paper
• Atorvastatin attenuates inflammatory infiltration and vascular remodeling in lung of hypercholesterolemia rabbits

  2010cites this paper
• Clinical benefits of statin pretreatment in patients undergoing coronary revascularization

  2010cites this paper
• Influence of insulin resistance on long-term outcomes in patients.

  2010cites this paper
• Preprocedural statin therapy to prevent myocardial damage in percutaneous coronary intervention: a review of randomized trials.

  2010cites this paper